Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil
出版年份 2023 全文链接
标题
Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil
作者
关键词
-
出版物
Neuroscience Bulletin
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-28
DOI
10.1007/s12264-023-01138-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry
- (2023) Merja Joensuu et al. EMBO JOURNAL
- Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
- (2023) Zheng Liu et al. Nature Communications
- A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication
- (2022) Adam Strzelczyk et al. CNS DRUGS
- Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)
- (2022) Burcu A. Pazarlar et al. Molecular Brain
- Synaptic Vesicle Glycoprotein 2A: Features and Functions
- (2022) Rachele Rossi et al. Frontiers in Neuroscience
- Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
- (2022) Oliver D. Howes et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials
- (2022) Michael Rademacher et al. Epilepsia Open
- An update on brivaracetam for the treatment of pediatric partial epilepsy
- (2021) Eleonora Tulli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis
- (2021) Taolin Fang et al. Neurocritical Care
- Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA A receptors
- (2020) Isabelle Niespodziany et al. EPILEPSIA
- An epilepsy-associated SV2A mutation disrupts synaptotagmin-1 expression and activity-dependent trafficking
- (2020) Callista B. Harper et al. JOURNAL OF NEUROSCIENCE
- Mechanisms of action of currently used antiseizure drugs
- (2020) Graeme J. Sills et al. NEUROPHARMACOLOGY
- Clinical experience with brivaracetam in a series of 46 children
- (2020) Núria Visa-Reñé et al. EPILEPSY & BEHAVIOR
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
- (2020) Wolfgang Löscher et al. PHARMACOLOGICAL REVIEWS
- Impact of predictive, preventive and precision medicine strategies in epilepsy
- (2020) Rima Nabbout et al. Nature Reviews Neurology
- Synaptic vesicle protein 2: A multi-faceted regulator of secretion
- (2019) Kristine Ciruelas et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Epilepsy in adults
- (2019) Roland D Thijs et al. LANCET
- Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients
- (2019) Edwin Liu et al. PEDIATRIC DRUGS
- The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
- (2019) Kristen A. Stout et al. ACS Chemical Neuroscience
- Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience
- (2019) Sara McGuire et al. JOURNAL OF CHILD NEUROLOGY
- Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models
- (2019) Karine Leclercq et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor
- (2019) Martyn Wood et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Treatment with brivaracetam in children – The experience of a pediatric epilepsy center
- (2019) Andreea Nissenkorn et al. EPILEPSY & BEHAVIOR
- Levetiracetam
- (2018) Paul Howard et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Epilepsy
- (2018) Orrin Devinsky et al. Nature Reviews Disease Primers
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
- (2017) Jerome Niquet et al. EPILEPSIA
- Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis
- (2017) Qingting Hu et al. JOURNAL OF NEUROLOGY
- Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets
- (2017) Ying C. Li et al. PHARMACOLOGICAL REVIEWS
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Brivaracetam: a novel antiepileptic drug for focal-onset seizures
- (2017) Linda J. Stephen et al. Therapeutic Advances in Neurological Disorders
- A New SV2A Ligand for Epilepsy
- (2016) Michael A. Rogawski CELL
- Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
- (2016) Wolfgang Löscher et al. CNS DRUGS
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?
- (2016) María Clara Gravielle PHARMACOLOGICAL RESEARCH
- Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
- (2016) Michael A. Rogawski et al. Cold Spring Harbor Perspectives in Medicine
- Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies
- (2015) Reetta Kälviäinen et al. EPILEPSIA
- Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking
- (2015) Elizabeth García-Pérez et al. EPILEPSIA
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam augments short-term depression and slows vesicle recycling
- (2015) Xiaofeng Yang et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- Phosphorylation of Synaptic Vesicle Protein 2A at Thr84 by Casein Kinase 1 Family Kinases Controls the Specific Retrieval of Synaptotagmin-1
- (2015) N. Zhang et al. JOURNAL OF NEUROSCIENCE
- Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
- (2014) Isabelle Niespodziany et al. CNS Neuroscience & Therapeutics
- Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
- (2014) Christian Vogl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter inSaccharomyces cerevisiae
- (2014) Marianna Madeo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Inhibition of Ca2+-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs
- (2013) Saeko Harada et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Brivaracetam Disposition in Mild to Severe Hepatic Impairment
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- New avenues for anti-epileptic drug discovery and development
- (2013) Wolfgang Löscher et al. NATURE REVIEWS DRUG DISCOVERY
- Levetiracetam Use in the Critical Care Setting
- (2013) Jennifer L. DeWolfe et al. Frontiers in Neurology
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
- (2012) Wim Van Paesschen et al. EPILEPSIA
- Brivaracetam Disposition in Renal Impairment
- (2012) Maria Laura Sargentini-Maier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pegloticase
- (2011) Katherine A. Lyseng-Williamson DRUGS
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam
- (2011) Anna L. Meehan et al. JOURNAL OF NEUROPHYSIOLOGY
- Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
- (2011) Amy Nowack et al. PLoS One
- Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus
- (2010) Yuki Sugaya et al. BRAIN RESEARCH
- Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
- (2010) Henrik Klitgaard EPILEPSIA
- Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study
- (2010) Patrick Kwan et al. EPILEPSY & BEHAVIOR
- Cotrafficking of SV2 and Synaptotagmin at the Synapse
- (2010) J. Yao et al. JOURNAL OF NEUROSCIENCE
- Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial
- (2010) J. A. French et al. NEUROLOGY
- 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice
- (2010) Rafal M. Kaminski et al. NEUROPHARMACOLOGY
- SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
- (2010) Felix L. Yeh et al. PLoS Pathogens
- Synaptotagmin-Mediated Bending of the Target Membrane Is a Critical Step in Ca2+-Regulated Fusion
- (2009) Enfu Hui et al. CELL
- Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures
- (2009) Jesus Eric Piña-Garza et al. EPILEPSIA
- Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam
- (2009) Rafal M. Kaminski et al. EPILEPSIA
- Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture
- (2009) Cristina Zona et al. EPILEPSY RESEARCH
- SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
- (2009) W.-P. Chang et al. JOURNAL OF NEUROSCIENCE
- Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission
- (2009) Xiao-Feng Yang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats
- (2008) Doru-Georg Margineanu et al. BRAIN RESEARCH BULLETIN
- The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
- (2008) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Brivaracetam: a rational drug discovery success story
- (2008) M A Rogawski BRITISH JOURNAL OF PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological Management of Epilepsy
- (2008) Cecilie Johannessen Landmark et al. DRUGS
- Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model
- (2008) Lyudmila V. Vinogradova et al. EPILEPSIA
- Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures
- (2008) Xun-Yi Wu et al. EPILEPSIA
- Brivaracetam: a new drug in development for epilepsy and neuropathic pain
- (2008) Barbara Malawska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
- (2008) S. Noachtar et al. NEUROLOGY
- Fragment-Based Approach to Drug??Lead Discovery
- (2008) Daniela Fattori et al. Drugs in research & development
- SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy
- (2007) Rafal M. Kaminski et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started